Resum
The blood-brain barrier (BBB) is a formidable physical and enzymatic barrier that tightly controls the passage of molecules from the blood to the brain. In fact, less than 2 % of all potential neurotherapeutics are able to cross it. Here, by applying the retro-enantio approach to a peptide that targets the transferrin receptor, a full protease-resistant peptide with the capacity to act as a BBB shuttle was obtained and thus enabled the transport of a variety of cargos into the central nervous system.
| Idioma original | Anglès |
|---|---|
| Pàgines (de-a) | 3967-3972 |
| Nombre de pàgines | 6 |
| Revista | Angewandte Chemie - International Edition |
| Volum | 54 |
| Número | 13 |
| DOIs | |
| Estat de la publicació | Publicada - 23 de març 2015 |
| Publicat externament | Sí |